000 | 02854nam a22004457a 4500 | ||
---|---|---|---|
008 | 210217s20212021 xxu||||| |||| 00| 0 eng d | ||
022 | _a0003-4975 | ||
024 | _a10.1016/j.athoracsur.2020.12.038 [doi] | ||
024 | _aS0003-4975(21)00074-6 [pii] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a33465365 | ||
245 | _aThe Society of Thoracic Surgeons Intermacs 2020 Annual Report. [Review] | ||
251 | _aAnnals of Thoracic Surgery. 111(3):778-792, 2021 03. | ||
252 | _aAnn Thorac Surg. 111(3):778-792, 2021 03. | ||
252 | _zAnn Thorac Surg. 2021 Jan 16 | ||
253 | _aThe Annals of thoracic surgery | ||
260 | _c2021 | ||
260 | _fFY2021 | ||
265 | _saheadofprint | ||
265 | _sppublish | ||
266 | _d2021-02-17 | ||
268 | _aAnnals of Thoracic Surgery. 2021 Jan 16 | ||
501 | _aAvailable online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007 | ||
520 | _aThe STS-Intermacs 2020 Annual Report reviews outcomes on 25,551 patients undergoing primary isolated continuous flow left ventricular assist device (LVAD) implantation between 2010-2019. In 2019, 3,198 primary LVADs were implanted, which is the highest annual volume in Registry history. Compared with the previous era (2010-2014), patients implanted in the most recent era (2015-2019) were more likely to be African American (26.8% vs. 22.9%, P<.0001) and more likely to be bridged to durable LVAD with temporary mechanical support devices (36.8% vs 26.0%, P<.0001). In 2019, 50% of patients were INTERMACS 1-2 prior to durable LVAD and 73% were implanted as destination therapy. Maglev technology has become the predominant design, accounting for 77% of devices in 2019. The 1- and 2-year survival in the most recent era has improved compared to 2010-2014 (82.3% and 73.1% vs. 80.5% and 69.1%, respectively; P<.0001). Major bleeding and infection continue to be the leading adverse events. Incident stroke has declined in the current era to 12.7% at one-year. STS-Intermacs research publications are highlighted herein and the new quality initiatives are introduced. Copyright (c) 2021. Published by Elsevier Inc. | ||
546 | _aEnglish | ||
650 | _a*Heart Failure/su [Surgery] | ||
650 | _a*Heart-Assist Devices | ||
650 | _a*Registries | ||
650 | _a*Societies, Medical | ||
650 | _a*Surgeons | ||
650 | _a*Thoracic Surgery | ||
650 | _aHumans | ||
650 | _aUnited States | ||
651 | _aMedStar Heart & Vascular Institute | ||
657 | _aJournal Article | ||
700 | _aMolina, Ezequiel J | ||
790 | _aBadhwar V, Copeland H, Cornwell WK 3rd, Cowger JA, Fernandez FG, Habib RH, Jacobs JP, Kiernan MS, Kirklin JK, Koehl D, Molina EJ, Pagani FD, Shah P, Takeda K | ||
856 |
_uhttps://dx.doi.org/10.1016/j.athoracsur.2020.12.038 _zhttps://dx.doi.org/10.1016/j.athoracsur.2020.12.038 |
||
942 |
_cART _dArticle |
||
999 |
_c6049 _d6049 |